Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trident Clinical Research
Sydney, New South Wales, Australiaau.linkedin.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Trident Clinical Research was one of Australia’s largest and most respected CROs prior to its acquisition by INC Research. It completed over 500 clinical studies across Phases I–IV—including more than 100 Phase I studies—serving both emerging biotechs and global pharmaceutical companies. The company was known for leveraging Australia’s efficient regulatory environment to deliver rapid study timelines without the need for IND or CTA filings.
- Modalities
- Small moleculeBiologicMonoclonal antibody
- Industry
- Contract Research Organization
02
Partnerships
Emerging biotechsGlobal pharmaceutical companies
Beyond the preview
Go deeper on Trident Clinical Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trident Clinical Research.